Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 30.9.2025Techdow Pharma Netherlands B.V. (TED)5905CInhixa 4 000 IU (40 mg) /0,4 ml injekčný roztok v naplnenej injekčnej striekačke (sol inj 10x0,4 ml/40 mg (striek.inj.napl.skl. s krytom ihly))24.9.2025U
 30.9.2025B.Braun Melsungen AG (BME)27562Nutriflex peri (sol inf 5x2000 ml (vak PA/PP))30.9.2025R
 30.9.2025ARDEZ Pharma, spol. s r.o. (ARZ)5748DGrasil 100 mg filmom obalené tablety (tbl flm 4x100 mg (blis.PVC/PVDC/Al))30.11.2025Z
 30.9.2025ARDEZ Pharma, spol. s r.o. (ARZ)5750DGrasil 100 mg filmom obalené tablety (tbl flm 12x100 mg (blis.PVC/PVDC/Al))30.11.2025Z
 30.9.2025Swedish Orphan Biovitrum AB (publ) (BVR)6668EALTUVOCT 3 000 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x3000 IU + 3 ml solv. (liek.inj.skl. + striek.inj.napl.skl.))10.7.2025U
 30.9.2025Swedish Orphan Biovitrum AB (publ) (BVR)6663EALTUVOCT 250 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x250 IU + 3 ml solv. (liek.inj.skl. + striek.inj.napl.skl.))18.2.2025U
 29.9.2025Grünenthal GmbH (GNG)71897Lunaldin 200 mikrogramov sublingválne tablety (tbl slg 30x200 µg (blis.OPA/Al/PVC/papier/PE/Al))25.9.2025R
 29.9.2025Grünenthal GmbH (GNG)71901Lunaldin 400 mikrogramov sublingválne tablety (tbl slg 30x400 µg (blis.OPA/Al/PVC/papier/PE/Al))11.9.2025R
 29.9.2025Grünenthal GmbH (GNG)71905Lunaldin 800 mikrogramov sublingválne tablety (tbl slg 30x800 µg (blis.OPA/Al/PVC/papier/PE/Al))2.9.2025R
 29.9.2025Zentiva a.s. (ZNT-SK-2)36130Citalec 10 Zentiva (tbl flm 30x10 mg (blis.PVC/PVDC/Al))3.10.2025O
 29.9.2025Zentiva a.s. (ZNT-SK-2)3629CFurosemid-Slovakofarma (tbl 50x40 mg (blis.PVC/Al))3.10.2025O
 29.9.2025Zentiva, k.s. (ZNT-1)36443Agen 5 (tbl 90x5 mg (blis. PVC/PVDC/Al))3.10.2025O
 29.9.2025Zentiva, k.s. (ZNT-1)7819BPERSEN forte (cps dur 40(4x10)x87,5 mg/17,5 mg/17,5 mg (blis.PVC/PCTFE/Al))1.10.2025O
 29.9.2025Teva B.V. (TEV-NL-4)8611EAtorvastatin Teva 40 mg (tbl flm 90x40 mg (blis.PA/Al/PVC-Al))25.9.2025U
 29.9.2025Adamed Pharma S.A. (AFD)2191BBISEPTOL 400 mg/80 mg (tbl 28x480 mg (blis.PVC/Al))29.9.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)